Healthcare - Biotechnology - NASDAQ - US
$ 1.32
-6.38 %
$ 1.86 M
Market Cap
-0.13
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
69.54%
Net Income
Estimate
40.49%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Allarity Therapeutics, Inc.
ALLR has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ALLR
EBIT FORECAST
EBIT Forecast Chart ALLR
NET INCOME FORECAST
Net Income Chart ALLR